Marketing pieces

Discussion in 'Supernus' started by anonymous, Oct 4, 2017 at 10:43 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Please make our brands more visible on our marketing materials. We are lucky if the doctors pick them up to throw them in the trash, so if the name of our products isn’t clearly visible, they have no idea what theyre throwing away.
     

  2. anonymous

    anonymous Guest

    I get what you’re saying. You must be new though because 95% of our branded (not counting non branded educational) marketing pieces do have the brands very visible. It’s only some of the newer pieces that don’t with the idea that yes, like you said more often than not, the doc/staff toss our stuff in the trash. But if they see a brochure with some emojis on the front and no brand name maybe they flip through out of curiosity rather than tossing it this time. I’d rather have a Dr. flip through the data 1 time than toss it away and see the brand name 10 times.
     
  3. anonymous

    anonymous Guest

    OMG so our marketing strategy TODAY is don't list our product name on material because our ad boards tell us docs are over these products. Scary to think what TOMMOROW'S strategy looks like.
     
  4. anonymous

    anonymous Guest

    Where did you get “over these products” from? What was explained above is a basic marketing strategy.

    Should the goal of a marketing campaign be to get the most brand recognition before getting tossed in the trash? Or maybe use some strategy to get the customer engaged? Really wish this site wasn’t anonymous so we could put you on a list of “never promote to marketing”
     
  5. anonymous

    anonymous Guest

    What thick skin you have over there in marketing.
     
  6. anonymous

    anonymous Guest

    Not from marketing. Just a fellow rep, ashamed you got hired here. Keep grasping for straws on those insults/complaints though bud. Logic and reason are against you.
     
  7. anonymous

    anonymous Guest

    We should change our title from neuro sales to XR specialist. I’m serious. It would give us more credibility and stop docs from asking “what’s new”. The luxury we have is other reps are selling unique medications and therapies and we are selling “unique” delivery systems. We don’t even really need to know anything about disease state or brain chemistry. I was at an event and I overheard a UCB rep talking and I was actually embarrassed about my products. Good times hear...yeah yeah I know so quit. It’s hard to find another gig that pays what I make for doing as little as I do. I’ll ride this misery out till we’re acquired by a larger company or they get rid of the sales force all together.
     
  8. anonymous

    anonymous Guest


    I agree. When was the last time we talked about mechanisms of action? Different seizure types? Want to differentiate our products from the rest? How about give us some actual scientific data in our visaid instead of all the BS. Doctors can tell when you are selective and skew the data to make our products look better. It’s an old trick. Small sample sizes and “retrospective reviews” that aren’t even close to scientifically legitimate. Why don’t we talk about the fundamental reasons our products differ from every other product on the market. Revolutionary, I know.

    I guess if it doesn’t have an emoji or a flip phone, it doesn’t make the cut.
     
  9. anonymous

    anonymous Guest

    Hahaha the flip phone!
     
  10. anonymous

    anonymous Guest

    First: What are the fundamental differentiations we aren’t talking about?

    Second: If you need more fundamental differences to back the logical story with our products then you seriously may want to work on your actual selling skills. If human beings actually made decisions based on fundamental differences no one would ever buy a BMW, or iPhone, or any other overpriced product that offers little differentiation but has emotional selling points.
     
  11. anonymous

    anonymous Guest

    So are you conceding the point doctors say every day...We have an over priced product that they don’t need?
     
  12. anonymous

    anonymous Guest

    Mine don’t say that because I sold them then their patients saw real clinical benefit. We wouldn’t be doing as well as we are if our products were smoke and mirrors.

    Don’t know why I’m argueing with you. Sounds like you won’t be around long anyway.
     
  13. anonymous

    anonymous Guest

    ok. You sold them. Idiot. Why does Aptiom have more scripts in the market than OxtellarXR and we had a 2 year head start??? It’s not because the sales tram at Sunovion is that much better. It’s because they have talking my points that we don’t have. They have multiple clinical studies. We have 1. And let’s be honest with ourselves both products are the exact same thing. Like someone said before we are a generic drug company. Don’t let anyone pull the wool over your eyes. This is a good company to get your foot in the door into the industry of medical sales. If you can get a job with another company DO IT!!!. Supernus will be acquired by a larger company when ADHD becomes ready to hit the market. Watch...
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest


    1. You think they are the same = why you can’t move the drug. Same active metabolite yes... but Oxtellar yields more effective results. You’re the rep that probably uses lines like: can I have half of the aptiom you write? Or I’m goig to get fired if you don’t write more... Loser

    2. Regarding aptiom having more % of the market ... i guess it’s easy to forget that aptiom has an entire salesforce who’s only focus is that.... while in those two years Supernus focus was to literally to launch Trokendi and sell Oxtellar as much as possible for 3 targets... a call plan that literally had the equivalent of maybe 25 reps selling Oxtellar vs 150+ selling aptiom

    3. Emotion sells a lot more than logic but of course Enterprise doesn’t teach that. However since we’re being fair... can’t wait to see how much share you grow with Oxtellar once we get these clinical studies for new indication. I’m sure you’d use your visual aid more often with “better” data too
     
  16. anonymous

    anonymous Guest

    Yeah, just sell better moron!!! The only problem with Supernus is our poor attitude reps like you that blame marketing and our meds for poor performance. Take ownership, sell, and count yourself lucky you're with a company that has meds in the pipeline.
     
  17. anonymous

    anonymous Guest

    holy shit you guys are wasted on company coolaid! This job wears on you after a while and if you don’t appreciate that then you’re on the spectrum. I get having good sales dialogue and selling our XR generics, but you have to appreciate the feeling of Groundhogs Day after a few years with these meds. I’ll continue to make my calls in the AM and focus on my other gig in the afternoons. PS- Meg is the absolute hottest!!!
     
  18. anonymous

    anonymous Guest

    Former Supernus rep here and now working for a top 5 world wide company for the last several years. Hadn't check cafepharma in a long time, but was curious what the latest chatter was at Supernus (glad I don’t see Supernuts anymore). Anyway, I can assure you, there are plenty of opportunities out there beyond Supernus with greater base salary and bonus potential. Don’t sell yourself short. There was one post about getting your foot in the door with this company. That is absolutely true- not just about pharma but with any industry that you want to break into. Supernus, smartly, recognized that reps from other industries would be hungry to get into pharma. I was one of those reps and while I can’t say I was the most successful reps at Supernus, I can tell you that I cut my teeth, learned what NOT to do and found my way to another opportunity. Take advantage of Supernus, just as they took advantage of your eagerness to get out of your previous industry and move on.

    Out of curiosity, did they ever issue more stock options in addition the ones they gave you when hired?
     
  19. anonymous

    anonymous Guest

    What a loser. Couldn’t hack it here but you still wanted to drop by and see what’s going on. Do us all a favor and stay off cafepharma. Supernus is doing better than anyone in Migraine or Epilepsy and soon will be top on Psychiatic as well. Go away troll and leave the successful sales people alone.
     
  20. anonymous

    anonymous Guest

    No more stock options, but the CFO just sold 20,000 shares for a cool 800k